ISRCTN35811298已完成未知
An investigation of the functional significance of marginal riboflavin status in young women
niversity of Sheffield (UK)0 个研究点目标入组 120 人开始时间: 2007年8月2日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
2009 protocol in https://www.ncbi.nlm.nih.gov/pubmed/19323801 2011 results in https://www.ncbi.nlm.nih.gov/pubmed/21525198
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Women aged 19 to 25 years
- •2. Low milk consumption (less than 200 ml a day)
- •3. Healthy
- •4. Marginal riboflavin deficiency as measured by an Erythrocyte Glutathione Reductase Activation Coefficient of greater than 1.4; 1. Women aged 19 to 25 years
- •2. Low milk consumption (less than 200 ml a day)
- •3. Healthy
- •4. Marginal riboflavin deficiency as measured by an Erythrocyte Glutathione Reductase Activation Coefficient of greater than 1.4
排除标准
- •1. Use of multivitamin or iron supplements (within last three months)
- •2. Diagnosed gastrointestinal disorders
- •2.1. coeliac disease
- •2.2. ulcerative colitis
- •2.3. Crohns disease
- •2.4. inflammatory bowel disease
- •3. Blood donors
- •4. Haemochromatosis
- •5. Pregnancy; 1. Use of multivitamin or iron supplements (within last three months)
- •2. Diagnosed gastrointestinal disorders
- •2.1. coeliac disease
- •2.2. ulcerative colitis
- •2.3. Crohns disease
- •2.4. inflammatory bowel disease
- •3. Blood donors
- •4. Haemochromatosis
- •5. Pregnancy
研究者
相似试验
已完成
不适用
Evaluating the effectiveness of a Diabetes Needs Assessment Tool (DNAT): a randomised controlled trialDiabetesISRCTN67215088BMJ Group (UK)200
已完成
不适用
Brief psychological therapy compared to general practitioners care for depression in primary care: a randomised controlled trialDepressionMental and Behavioural DisordersDepressive episodeISRCTN65811640etherlands Organisation for Health Research and Development (ZonMw) (Netherlands)122
已完成
不适用
A study to determine the maintenance of efficacy of agomelatine to prevent relapse in out-patients with major depressive disorder. A 8 to 10 weeks open period treatment with agomelatine followed by 24 weeks randomised double-blind period, placebo-controlled, parallel groups and 20 weeks of optional double-blind treatment period.Major depressive disorderMental and Behavioural DisordersDepressive disorderISRCTN53193024Institut de Recherches Internationales Servier (France)500
已完成
不适用
Implementation and evaluation of two different cognitive stimulation therapy training approachesMental and Behavioural DisordersDementiaISRCTN28793457orth East London NHS Foundation Trust (NELFT) (UK)240
已完成
不适用
Evaluating possible intended and unintended consequences of the implementation of Minimum Unit Pricing of Alcohol in Scotland: a natural experimentISRCTN16039407HS Greater Glasgow & Clyde20,640